Georg Pall

2.6k total citations
49 papers, 811 citations indexed

About

Georg Pall is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Georg Pall has authored 49 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 8 papers in Epidemiology. Recurrent topics in Georg Pall's work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (12 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Georg Pall is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (12 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Georg Pall collaborates with scholars based in Austria, Germany and United States. Georg Pall's co-authors include Wolfgang Hilbe, Christof Ludescher, Oliver Bechter, Thomas Kühr, Günther Gastl, Josef Thaler, Michael Steurer, August Zabernigg, Eveline U. Irschick and Guido Schwarzer and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Georg Pall

45 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Georg Pall Austria 17 362 195 166 161 135 49 811
Kimikazu Matsumoto Japan 20 237 0.7× 113 0.6× 117 0.7× 270 1.7× 154 1.1× 122 1.3k
Jennifer Hodge United States 11 223 0.6× 162 0.8× 384 2.3× 108 0.7× 83 0.6× 15 1.1k
Robert Debernardo United States 17 212 0.6× 153 0.8× 428 2.6× 228 1.4× 68 0.5× 39 1.2k
Ornella Belvedere Italy 14 213 0.6× 257 1.3× 398 2.4× 169 1.0× 58 0.4× 40 1.1k
Rachel Kobos United States 18 359 1.0× 97 0.5× 98 0.6× 315 2.0× 61 0.5× 65 830
Simona Secondino Italy 18 687 1.9× 227 1.2× 261 1.6× 206 1.3× 111 0.8× 59 1.2k
Viswanath Reddy Belum United States 17 649 1.8× 140 0.7× 95 0.6× 208 1.3× 60 0.4× 25 1.1k
Yung‐Chang Lin Taiwan 19 664 1.8× 167 0.9× 533 3.2× 273 1.7× 63 0.5× 49 1.3k
Akitoshi Kinoshita Japan 19 516 1.4× 198 1.0× 119 0.7× 440 2.7× 68 0.5× 93 1.2k
Roberta Schiavo Italy 19 687 1.9× 126 0.6× 402 2.4× 213 1.3× 116 0.9× 40 1.3k

Countries citing papers authored by Georg Pall

Since Specialization
Citations

This map shows the geographic impact of Georg Pall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Pall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Pall more than expected).

Fields of papers citing papers by Georg Pall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg Pall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Pall. The network helps show where Georg Pall may publish in the future.

Co-authorship network of co-authors of Georg Pall

This figure shows the co-authorship network connecting the top 25 collaborators of Georg Pall. A scholar is included among the top collaborators of Georg Pall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg Pall. Georg Pall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Horvath, Lena & Georg Pall. (2023). ESMO 2022 personal non-small lung cancer (NSCLC) highlights. memo - Magazine of European Medical Oncology. 16(2). 97–99. 1 indexed citations
2.
Olschewski, Horst, Florian Kocher, Gudrun Absenger, et al.. (2021). Real-world experience with anti-PD-1/PD-L1 monotherapy in patients with non-small cell lung cancer. Wiener klinische Wochenschrift. 133(21-22). 1122–1130. 4 indexed citations
3.
Pall, Georg. (2020). Neoadjuvant immunotherapy in nonsmall cell lung cancer. Current Opinion in Oncology. 33(1). 59–63. 5 indexed citations
4.
Sopper, Sieghart, Arno Amann, Andreas Pircher, et al.. (2020). Systematic review: Soluble immunological biomarkers in advanced non-small-cell lung cancer (NSCLC). Critical Reviews in Oncology/Hematology. 153. 102948–102948. 21 indexed citations
5.
Reinstadler, Vera, et al.. (2019). Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine. European Journal of Drug Metabolism and Pharmacokinetics. 44(6). 845–851. 4 indexed citations
7.
Pall, Georg, et al.. (2016). Targeted Therapies for the Treatment of Brain Metastases in Solid Tumors. Targeted Oncology. 11(3). 263–275. 11 indexed citations
9.
Fiegl, Michael, Andreas Pircher, Gabriele Gamerith, et al.. (2014). Small steps of improvement in small-cell lung cancer (SCLC) within two decades: A comprehensive analysis of 484 patients. Lung Cancer. 84(2). 168–174. 23 indexed citations
10.
Pall, Georg, Christian Pirich, Martin Hoffmann, et al.. (2014). Therapie des Patienten mit Radioiod-refraktärem, differenziertem Schilddrüsenkarzinom. Nuklearmedizin - NuclearMedicine. 54(3). 125–130. 2 indexed citations
11.
Pircher, Andreas, Gabriele Gamerith, Arno Amann, et al.. (2014). Neoadjuvant chemo-immunotherapy modifies CD4+CD25+ regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients. Lung Cancer. 85(1). 81–87. 44 indexed citations
12.
Seeber, Andreas, Manfred Mitterer, Eberhard Gunsilius, et al.. (2013). Feasibility of a Multdisciplinary Lung Cancer Videoconference between a Peripheral Hospital and a Comprehensive Cancer Centre. Oncology. 84(3). 186–190. 14 indexed citations
13.
Zabernigg, August, Johannes M. Giesinger, Georg Pall, et al.. (2012). Quality of life across chemotherapy lines in patients with cancers of the pancreas and biliary tract. BMC Cancer. 12(1). 390–390. 32 indexed citations
14.
Bale, Reto, Gerlig Widmann, Peter Schullian, et al.. (2011). Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases. European Radiology. 22(4). 930–937. 87 indexed citations
15.
Pall, Georg. (2010). Lung cancer – ASCO 2010. memo - Magazine of European Medical Oncology. 3(4). 172–176.
16.
Fiegl, Michael, August Zabernigg, Georg Pall, et al.. (2007). Das kleinzellige Bronchialkarzinom. Wiener klinische Wochenschrift. 119(23-24). 697–710. 3 indexed citations
17.
Lakos, Gabriella, Magdolna Aleksza, Edit Gyimesi, et al.. (2004). Association between the occurrence of the anticardiolipin IgM and mite allergen‐specific IgE antibodies in children with extrinsic type of atopic eczema/dermatitis syndrome. Allergy. 59(2). 164–167. 17 indexed citations
18.
Bechter, Oliver, Wolfgang Eisterer, S Dirnhofer, et al.. (1999). Expression of LFA-1 identifies different prognostic subgroups in patients with advanced follicle center lymphoma (FCL). Leukemia Research. 23(5). 483–488. 12 indexed citations
19.
Ludescher, Christof, Georg Pall, Eveline U. Irschick, & Günther Gastl. (1998). Differential activity of P‐glycoprotein in normal blood lymphocyte subsets. British Journal of Haematology. 101(4). 722–727. 59 indexed citations
20.
Pall, Georg, Martin Spitaler, Johann Hofmann, J. Thaler, & Christof Ludescher. (1997). Multidrug resistance in acute leukemia: a comparison of different diagnostic methods. Leukemia. 11(7). 1067–1072. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026